FindTrial
Sign In

A study on the Effect of Haritakyadi Kwath and Yavakshar in Men (40-80 Years) with Benign Prostatic Hyperplasia

A Randomised Controlled Clinical Trial to Assess The Efficacy of Haritakyadi Kwath and Yavakshar in Management of Vatastheela W.S.R to Benign Prostatic Hyperplasia - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080616
Enrollment
60
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

Dr VJD Gramin Ayurved Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with classical signs and symptoms of Benign Prostatic Hyperplasia

Exclusion criteria

Exclusion criteria: CA Prostate Urethral stricture Benign tumor of urethra Malignant tumor of urethra Urethral injury Urethral calculi Age above 80 years and below 40 years Patients with systemic diseases like uncontrolled Hypertension (more than 150/90 mm Hg) and uncontrolled Diabetes mellitus (RBS more than 180 mg/dl), Tuberculosis, STD, HIV, HBSAg

Design outcomes

Primary

MeasureTime frame
Subjective criteria Quality of life due to urinary symptoms International prostate symptoms score IPSS Objective criteria Prostate size (volume) by USG Residual urine volume by USG Urine flow rateTimepoint: Before treatment and after treatment and follow up at 15 and 30 days—

Secondary

MeasureTime frame
Decrease in symptoms of Vatastheela and Quality of life due to urinary symptomsTimepoint: 18 months—

Countries

India

Contacts

Public ContactDr Ganesh Belorkar

Dr VJD Gramin Ayurved Mahavidyalaya

Ganeshbelorkar@gmail.com7972681655

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026